-
Mashup Score: 0Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20-44 Years - 1 year(s) ago
This study assesses the prevalence rates of cardiovascular risk factors (hypertension, diabetes, hyperlipidemia, obesity, and tobacco use), treatment, and control among adults aged 20 to 44 years from 2009 through March 2020, overall and by sex and race and ethnicity.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Challenges in the treatment of young people with type 2 diabetes - 1 year(s) ago
The increasing prevalence of obesity in children and adolescents has been followed by an increased rate of type 2 diabetes.1 In children and adolescents, type 2 diabetes takes a more aggressive course than in adults with a more rapid decline in β-cell function, high treatment failure, and accelerated development of diabetes-related complications.2 Pharmacological treatments approved by the…
Categories: Endocrinology, Latest HeadlinesTweet-
Also read Sten Madsbad on: Challenges in the treatment of #young #people with type 2 #diabetes https://t.co/VshrCtZo8q #T2D
-
-
Mashup Score: 3
Empagliflozin provided clinically relevant placebo-corrected reductions in HbA1c, whereas linagliptin did not, and might offer a new treatment option for young people with type 2 diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
Online—Efficacy & safety of the #SGLT2 inhibitor #empagliflozin vs placebo and the #DPP-4 inhibitor #linagliptin versus placebo in #young #people with type 2 #diabetes (#DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial https://t.co/fdz3fO0EJm #T2D
-
-
Mashup Score: 0Challenges in the treatment of young people with type 2 diabetes - 1 year(s) ago
The increasing prevalence of obesity in children and adolescents has been followed by an increased rate of type 2 diabetes.1 In children and adolescents, type 2 diabetes takes a more aggressive course than in adults with a more rapid decline in β-cell function, high treatment failure, and accelerated development of diabetes-related complications.2 Pharmacological treatments approved by the…
Categories: Endocrinology, Latest HeadlinesTweet-
Sten Madsbad comments on: Challenges in the treatment of #young #people with type 2 #diabetes https://t.co/VshrCtZo8q #T2D
-
-
Mashup Score: 2
Childhood, adolescent, and young adult cancer survivors are at increased risk of reduced bone mineral density. Clinical practice surveillance guidelines are important for timely diagnosis and treatment of these survivors, which could improve bone mineral density parameters and prevent fragility fractures. Discordances across current late effects guidelines necessitated international harmonisation…
Categories: Endocrinology, Latest HeadlinesTweet-
Also read: #Bone mineral density surveillance for #childhood, #adolescent, and #young #adult #cancer #survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group https://t.co/aSAX4wmFpI #BMD #ChildhoodCancer Day
-
-
Mashup Score: 0
Empagliflozin provided clinically relevant placebo-corrected reductions in HbA1c, whereas linagliptin did not, and might offer a new treatment option for young people with type 2 diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
Online—Efficacy & safety of the #SGLT2 inhibitor #empagliflozin versus placebo & the #DPP-4 inhibitor #linagliptin versus placebo in #young #people with type 2 #diabetes (#DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial https://t.co/fdz3fO0EJm #T2D
-
-
Mashup Score: 0Challenges in the treatment of young people with type 2 diabetes - 1 year(s) ago
The increasing prevalence of obesity in children and adolescents has been followed by an increased rate of type 2 diabetes.1 In children and adolescents, type 2 diabetes takes a more aggressive course than in adults with a more rapid decline in β-cell function, high treatment failure, and accelerated development of diabetes-related complications.2 Pharmacological treatments approved by the…
Categories: Endocrinology, Latest HeadlinesTweet-
Sten Madsbad comments on: Challenges in the treatment of #young #people with type 2 #diabetes https://t.co/VshrCtZo8q #T2D
-
-
Mashup Score: 1
Empagliflozin provided clinically relevant placebo-corrected reductions in HbA1c, whereas linagliptin did not, and might offer a new treatment option for young people with type 2 diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
Efficacy and safety of the #SGLT2 inhibitor #empagliflozin versus placebo and the #DPP-4 inhibitor #linagliptin versus placebo in #young #people with type 2 #diabetes (#DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial https://t.co/fdz3fO0EJm #T2D
-
-
Mashup Score: 0Challenges in the treatment of young people with type 2 diabetes - 1 year(s) ago
The increasing prevalence of obesity in children and adolescents has been followed by an increased rate of type 2 diabetes.1 In children and adolescents, type 2 diabetes takes a more aggressive course than in adults with a more rapid decline in β-cell function, high treatment failure, and accelerated development of diabetes-related complications.2 Pharmacological treatments approved by the…
Categories: Endocrinology, Latest HeadlinesTweet-
Also read the Linked Comment: Challenges in the treatment of #young #people with type 2 #diabetes https://t.co/VshrCtZo8q #T2D
-
-
Mashup Score: 0
Empagliflozin provided clinically relevant placebo-corrected reductions in HbA1c, whereas linagliptin did not, and might offer a new treatment option for young people with type 2 diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
Online—Efficacy & safety of the #SGLT2 inhibitor #empagliflozin vs placebo & the #DPP-4 inhibitor #linagliptin versus placebo in #young #people with type 2 #diabetes (#DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial https://t.co/fdz3fO0EJm #T2D
-
#CVR in #young adults in US #CardioTwitter #ACC23 https://t.co/MZPwX1WuVP